NASS 2019 Annual Meeting

Alpesh Patel, MD, FACS




Royalties: Amedica (B); Stock Ownership: Amedica (<1%), Cytonics (<1%), Nocimed (<1%), Vital5 (<1%), Endoluxe (<1%), Tissue Differentiation Intelligence (<1%); Consulting: Amedica (None), Zimmer Biomet (B), DePuy Synthes (None), NuVasive (None), Kuros Biosciences (None); Board of Directors: Cervical Spine Research Society (Nonfinancial), Lumbar Spine Research Society (Nonfinancial); Scientific Advisory Board: Kuros Biosciences (None); Grants: Cervical Spine Research Society (A, Paid directly to institution/employer); Fellowship Support: AOSpine North America (E, Paid directly to institution/employer), NuVasive (D, Paid directly to institution/employer).

Sessions :